CVS Health Corp (CVS) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
CVS Health Corp stock (CVS) is currently trading at $71.48. CVS Health Corp PE ratio is 51.42. CVS Health Corp PS ratio (Price-to-Sales) is 0.23. Analyst consensus price target for CVS is $96.50. WallStSmart rates CVS as Hold.
CVS Health Corp (CVS) stock price prediction for 2030: Base case $155.01. Bull case $193.76. Bear case $116.26. See full CVS 2030 price forecast and methodology on WallStSmart.
- CVS PE ratio analysis and historical PE chart
- CVS PS ratio (Price-to-Sales) history and trend
- CVS intrinsic value — DCF, Graham Number, EPV models
- CVS stock price prediction 2025 2026 2027 2028 2029 2030
- CVS fair value vs current price
- CVS insider transactions and insider buying
- Is CVS undervalued or overvalued?
- CVS Health Corp financial analysis — revenue, earnings, cash flow
- CVS Piotroski F-Score and Altman Z-Score
- CVS analyst price target and Smart Rating
CVS Health Corp
📊 No data available
Try selecting a different time range
CVS Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · CVS Health Corp (CVS)
CVS trades 18% above its Graham fair value of $65.05, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
CVS Health Corp (CVS) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in market cap, peg ratio, price/sales. Concerns around return on equity and operating margin. Fundamentals are solid but monitor weak areas for improvement.
CVS Health Corp (CVS) Key Strengths (6)
Growing significantly faster than its price suggests
Paying less than $1 for every $1 of annual revenue
Earnings per share surging 76.60% year-over-year
90.80% of shares held by major funds and institutions
Large-cap company with substantial market presence
Trading at 1.21x book value, attractively priced
Supporting Valuation Data
CVS Health Corp (CVS) Areas to Watch (4)
Very low returns on shareholder equity
Near-zero operating margins, business under pressure
Very thin margins, barely profitable
Modest revenue growth at 8.40%
Supporting Valuation Data
CVS Health Corp (CVS) Detailed Analysis Report
Overall Assessment
This company scores 65/100 in our Smart Analysis, earning a C+ grade. Out of 10 metrics analyzed, 6 register as strengths (avg 9.5/10) while 4 fall into concern territory (avg 2.0/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on PEG Ratio, Price/Sales, EPS Growth. Valuation metrics including PEG Ratio (0.21), Price/Sales (0.23), Price/Book (1.21) suggest the stock is attractively priced. Growth metrics are encouraging with EPS Growth at 76.60%.
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Profit Margin. Growth concerns include Revenue Growth at 8.40%, which may limit upside. Profitability pressure is visible in Return on Equity at 2.29%, Operating Margin at 1.57%, Profit Margin at 0.44%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 2.29% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 8.40% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. The weight of evidence leans positive, with more strengths than concerns. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (PEG Ratio, Price/Sales) and negatives (Return on Equity, Operating Margin). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
WallStSmart Analysis Synopsis
Data-driven financial summary for CVS Health Corp (CVS) · HEALTHCARE › HEALTHCARE PLANS
The Big Picture
CVS Health Corp is a mature, profitable business with steady cash generation. Revenue reached 399.8B with 8% growth year-over-year. Profit margins are strong at 44.0%, reflecting pricing power and operational efficiency.
Key Findings
ROE of 229.0% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
Profit margin of 44.0% and operating margin of 157.0% demonstrate strong pricing power and operational efficiency.
What to Watch Next
Valuation compression risk at a P/E of 51.4x. Any growth miss could trigger a sharp correction.
Dividend sustainability with a current yield of 3.7%. Watch payout ratio and free cash flow coverage.
Debt management: total debt of 93.6B is significantly higher than cash (8.5B). Monitor refinancing risk.
Sector dynamics: monitor HEALTHCARE PLANS industry trends, competitive moves, and regulatory changes that could impact CVS Health Corp.
Bottom Line
CVS Health Corp is a well-established business delivering consistent profitability with 44.0% margins. The growth phase may be slowing, but strong cash generation and operational efficiency make it suitable for investors seeking reliability over excitement.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About CVS Health Corp(CVS)
NYSE
HEALTHCARE
HEALTHCARE PLANS
USA
CVS Health (previously CVS Corporation and CVS Caremark Corporation) is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; Aetna, a health insurance provider, among many other brands. The company's headquarters is in Woonsocket, Rhode Island.